- Home
- MYFW vs OBIO Comparison
MYFW vs OBIO Comparison
Compare MYFW & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- OBIO
- Stock Information
- Founded
- MYFW 2002
- OBIO 2017
- Country
- MYFW United States
- OBIO United States
- Employees
- MYFW N/A
- OBIO N/A
- Industry
- MYFW Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- MYFW Finance
- OBIO Health Care
- Exchange
- MYFW Nasdaq
- OBIO Nasdaq
- Market Cap
- MYFW 198.1M
- OBIO 200.1M
- IPO Year
- MYFW 2018
- OBIO N/A
- Fundamental
- Price
- MYFW $20.82
- OBIO $5.44
- Analyst Decision
- MYFW Buy
- OBIO Strong Buy
- Analyst Count
- MYFW 3
- OBIO 4
- Target Price
- MYFW $21.33
- OBIO $15.75
- AVG Volume (30 Days)
- MYFW 45.3K
- OBIO 61.0K
- Earning Date
- MYFW 10-24-2024
- OBIO 11-12-2024
- Dividend Yield
- MYFW N/A
- OBIO N/A
- EPS Growth
- MYFW N/A
- OBIO N/A
- EPS
- MYFW 0.26
- OBIO N/A
- Revenue
- MYFW $79,649,000.00
- OBIO $2,647,000.00
- Revenue This Year
- MYFW N/A
- OBIO $7.68
- Revenue Next Year
- MYFW $13.44
- OBIO $110.40
- P/E Ratio
- MYFW $79.71
- OBIO N/A
- Revenue Growth
- MYFW N/A
- OBIO N/A
- 52 Week Low
- MYFW $12.84
- OBIO $4.22
- 52 Week High
- MYFW $21.87
- OBIO $11.69
- Technical
- Relative Strength Index (RSI)
- MYFW 59.42
- OBIO 46.49
- Support Level
- MYFW $20.40
- OBIO $5.01
- Resistance Level
- MYFW $20.77
- OBIO $6.50
- Average True Range (ATR)
- MYFW 0.66
- OBIO 0.49
- MACD
- MYFW 0.07
- OBIO -0.09
- Stochastic Oscillator
- MYFW 84.37
- OBIO 28.91
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.